SEC Form 4 reporting owner

Congleton Jon

Congleton Jon has filed 14 Form 4 transactions reported between November 21, 2025 and July 13, 2026, as Chief Executive Officer of Mineralys Therapeutics, Inc. and Director of IMMUNIC, INC..

Name as filed: Congleton Jon

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$5.2M

9 lines

Companies

with Form 4 filings

Latest transaction

Jul 13, 2026

transaction date

Roles and reported holdings

MLYSMineralys Therapeutics, Inc.
Nov 21, 2025 – Jul 13, 2026
Chief Executive Officer
Held directly603,621 sh as of Jul 13, 2026 · Form 4
24 months: $5.2M sold
IMUXIMMUNIC, INC.
Jun 29, 2026 – Jul 5, 2026
Director
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 14 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Jul 13, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	10,700	$27.24	$291K@ $27.24	603,621	Form 4
Jul 5, 2026	IMUXDirector	Grant or awardCode A · direct	25,370	—	—	25,370	Form 4
Jun 30, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	17,000	$26.82	$456K@ $26.82	614,321	Form 4
Jun 30, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	58,000	$25.94	$1.5M@ $25.94	631,321	Form 4
Jun 29, 2026	IMUXDirector	Grant or awardCode A · direct	50,740	—	—	50,740	Form 4
Apr 13, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	15,730	$26.83	$422K@ $26.83	689,321	Form 4
Mar 31, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	453	$27.05	$12K@ $27.05	705,051	Form 4
Mar 31, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	55,183	$26.54	$1.5M@ $26.54	705,504	Form 4
Mar 31, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	19,364	$25.50	$494K@ $25.50	760,687	Form 4
Feb 19, 2026	MLYSChief Executive Officer	Grant or awardCode A · direct	187,900	—	—	187,900	Form 4
Feb 19, 2026	MLYSChief Executive Officer	Grant or awardCode A · direct	140,900	—	—	780,051	Form 4
Jan 12, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	7,117	$33.15	$236K@ $33.15	639,151	Form 4
Jan 12, 2026	MLYSChief Executive Officer	Open-market saleCode S · direct	9,119	$32.21	$294K@ $32.21	646,268	Form 4
Nov 21, 2025	MLYSChief Executive Officer	Option exerciseCode M · direct	24,082	$0.5400	$13K@ $0.5400	655,387	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.